Pricing Log in Create free account
Saturday 17 October 2026 Export MCK’s income statement to Excel — free account

McKesson Corporation

MCK Healthcare Medical Distribution

McKesson Corporation’s revenue for fiscal 2026 (year ended March 2026) was $403.4 billion, up 12.4% from fiscal 2025. In the quarter to June 2026, revenue grew 7.72%, EPS fell 17.7%, free cash flow grew 66.4% and total debt rose 10.5%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years, revenue growth for ten.

1,006.92 8.28 +0.83%
Market cap
$116.4B
P/E
26.8×
Fwd P/E
18.3×
Dividend yield
0.34%
F-score
7/9
Altman Z
6.15
Beneish M
−2.34
Dividend safety
86/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

McKesson Corporation (MCK) EV/EBITDA

Alert me on EV/EBITDA

As of 16 October 2026, McKesson Corporation (MCK) trades at a EV/EBITDA of 17.8×. Over the past ten years it has ranged from 0.0× (December 2021) to 21.8× (November 2024); the current reading is higher than 81% of that period. That is in line with the Medical Distribution industry median of 17.8× and above the Healthcare sector median of 9.2×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2026 16.5× (8.53%)
FY2025 18.1× 4.33%
FY2024 17.3× 49.39%
FY2023 11.6× (42.33%)
FY2022 20.1× —
FY2021 0.0× —
FY2020 7.8× 9.69%
FY2019 7.1× (18.17%)
FY2018 8.7× 88.46%
FY2017 4.6× (48.93%)

Quarterly newest first

Period EV/EBITDA Change
Jun 2026 13.7× (17.17%)
Mar 2026 16.5× (4.68%)
Dec 2025 17.3× (2.24%)
Sep 2025 17.7× (12.65%)
42 more quarters

Against its own ten years

Low 0.0× High 21.8×
Ten-year median 10.4×
Current reading's percentile 81

EV/EBITDA against peers

Company EV/EBITDA
HKPD Cellyan Biotechnology Co., Ltd compare n/m
FOCL FocalTherics compare n/m
AHG Akso Health Group Sponsored ADR compare n/m
COSM Cosmos Health Inc. compare n/m
ACH Accendra Health, Inc. compare 8.1×
HSIC Henry Schein, Inc. compare 12.0×
MCK McKesson Corporation 17.8×
CAH Cardinal Health, Inc. compare 17.9×
COR Cencora, Inc. compare 18.2×
Medical Distribution industry median 17.8×
Healthcare sector median 9.2×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on MCK